What types of policy changes does Humana issue?

Humana regularly publishes coverage updates including prior authorization requirement changes, billing code additions or deletions, plan-type coverage modifications, and clinical policy revisions. PolicyChanges.app monitors these notices and summarizes the impact for providers.

How often does Humana update its policies?

Humana typically releases policy bulletins on a rolling basis throughout the year. Our system checks for new updates daily and adds them to this feed as soon as they are identified.

How many Humana policy changes are tracked here?

This page currently tracks 50 documented Humana policy changes. New items are added as they are identified.

What should I do when Humana changes a prior authorization policy?

Review each change's effective date and action-required notes. Update your billing and clinical workflows before the effective date to avoid claim denials. Each policy detail page on PolicyChanges.app includes a plain-English summary and action items.

Humana Policy Changes 2026 | Prior Auth & Coverage Updates

Humana Policy Changes & Prior Auth Updates

We track 50 documented policy changes from Humana across AK, AL, AR, AZ, CA and 5 more states. Each entry includes an AI-generated plain-English summary, effective date, affected billing codes, and a direct link to the original Humana notice. Use the related links below to narrow results by specialty or state, or sign up for a free daily alert to receive new Humana updates automatically.

High impact

Multiplex Pathogen Identification Panels for Infectious Disease - MEDICAID - KENTUCKY (Revised)

Humana·Effective Jun 29, 2026

Humana Kentucky Medicaid revised its multiplex pathogen identification panel policy effective 06/29/2026, establishing new coverage criteria for infectious disease testing including respiratory panels, vaginal bacterial vaginosis tests, tropical fever panels, and cell-free DNA metagenomic sequencing. Prior authorization is now required for BD MAX Vaginal Panel (81514), Karius Test (0152U), and Bridge Women's Health Infectious Disease Detection Test (0330U). Several tests including NeXGen Fungal/AFB NGS (0531U), Johns Hopkins Metagenomic NGS (0323U), BIOTIA-ID Urine NGS (0590U), and Taq Array Card UTI Panel (0593U) are explicitly non-covered.

Nonemergency Ambulance Transportation - MEDICAID - KENTUCKY (New)

Multiplex Pathogen Identification Panels for Infectious Disease - MEDICAID - KENTUCKY (Revised)

Iluvien® (fluocinolone acetonide) intravitreal implant (Revised)

Injections for Chronic Pain Conditions - MEDICAID - FLORIDA (Revised)

Spinal Fusion and Stabilization Surgery - MEDICAID - INDIANA (New)

Advanced Imaging of the Abdomen and Pelvis - Medicare Advantage (Revised)

Orthognathic Surgery - MEDICAID - VIRGINIA (New)

Injections for Chronic Pain Conditions - MEDICAID - VIRGINIA (Revised)

Injections for Chronic Pain Conditions - MEDICAID - MICHIGAN (New)

Injections for Chronic Pain Conditions - MEDICAID - ILLINOIS (New)

Anticholinergic Polypharmacy Agents (Revised)

Breyanzi® (lisocabtagene maraleucel) (Revised)

Kymriah™ (tisagenlecleucel) (Revised)

Breyanzi® (lisocabtagene maraleucel) (Revised)

Abecma® (idecabtagene vicleucel) (Revised)

Xgeva® (denosumab) and biosimilars (New)

Spinal Fusion Surgery - Medicare Advantage (Revised)

Knee Arthroscopy - Medicare Advantage (Revised)

Imfinzi (durvalumab) (New)

Bendamustine products (Treanda, Bendeka, Belrapzo, Vivimusta) (New)

Iclusig® (ponatinib) (Revised)

Pediatric Antipsychotic Utilization Program (Revised)

Molecular Diagnostic Assays and Breath Testing for Transplant Rejection - MEDICAID - FLORIDA (Revised)

Upper and Lower Extremity Magnetic Resonance Imaging (MRI) - Medicare Advantage (Revised)

Computer Assisted Surgical Navigation for Musculoskeletal Procedures - Medicare Advantage (New)

Comprehensive Genomic Profiling and Multigene Panel Testing for Solid Tumors - Medicare Advantage (Revised)

Home Health - MEDICAID - LOUISIANA (Revised)

Knee Arthroplasty - Medicare Advantage (Revised)

Hip Arthroplasty - Medicare Advantage (Revised)

Opioid Utilization Program - Morphine Milligram Equivalents (MME) edits (Revised)

Medical Necessity Determinations (New)

Cardiac Devices - MEDICAID - VIRGINIA (Revised)

Darzalex® (daratumumab) (New)

Aflibercept Products (Eylea®, Eylea® HD, Pavblu™) (New)

Spinal Decompression Surgery - Medicare Advantage (Revised)

Percutaneous Coronary Intervention - Medicare Advantage (Revised)

Roctavian™ (valoctocogene roxaparvovec-rvox) (Revised)

Pembrolizumab products (Keytruda, Keytruda Qlex) (New)

Pembrolizumab products (Keytruda, Keytruda Qlex) (New)

Pembrolizumab products (Keytruda, Keytruda Qlex) (New)

Wegovy (semaglutide) (Revised)

Spine Surgery - MEDICAID - OKLAHOMA (New)

Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (New)

Chiropractic - In Lieu of Services (ILOS) - MEDICAID - LOUISIANA (New)

Shoulder Arthroscopy - Medicare Advantage (New)

Hip Arthroscopy - Medicare Advantage (Revised)

Abuse Deterrent Oxycodone tablets (RoxyBond,Oxaydo, generics)

Zykadia (ceritinib) (Revised)

Zelboraf (vemurafenib) (Revised)

Xgeva® (denosumab) and biosimiliars (Revised)